PitchSend

Investor Presentaiton

Q2 2023 OLUMIANT SALES INCREASED 18% Millions U.S. sales were $51 million International sales were $168 million $256 $229 $219 $206 $186 $183 Q1 Q2 Q3 Q4 2022 2023 Not for promotional use • In the U.S., launched in rheumatoid arthritis in Q3 2018 and in alopecial areata in Q2 2022 Q2 year-over-year sales growth primarily driven by alopecia areata sales in the U.S. 2023 Q2 EARNINGS Lilly 35

View entire presentation